| Name | dimethyl 2-(1,3-dioxoisoindol-2-yl)pentanedioate |
|---|---|
| Synonyms |
dimethyl 2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)pentanedioate
dimethyl 2-(1,3-dioxoisoindolin-2-yl)-pentane-1,5-dioate dimethyl 2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-pentanedioate Dimethyl-2-N-phthalimidopentan-dioat |
| Density | 1.34g/cm3 |
|---|---|
| Boiling Point | 436.8ºC at 760 mmHg |
| Molecular Formula | C15H15NO6 |
| Molecular Weight | 305.28300 |
| Flash Point | 218ºC |
| Exact Mass | 305.09000 |
| PSA | 89.98000 |
| LogP | 0.71530 |
| Index of Refraction | 1.559 |
|
~72%
39739-04-3 |
| Literature: THE GOVERNMENT OF UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Patent: WO2005/28436 A2, 2005 ; Location in patent: Page/Page column 54 ; |
|
~%
39739-04-3 |
| Literature: Celgene Corporation Patent: US5874448 A1, 1999 ; Title/Abstract Full Text Show Details Celgene Corporation Patent: US5955476 A1, 1999 ; |